{"id":"https://openalex.org/W2064375261","doi":"https://doi.org/10.1158/1538-7445.am2011-558","title":"Abstract 558: Targeting tumour heparanase activity using fully human monoclonal antibodies","display_name":"Abstract 558: Targeting tumour heparanase activity using fully human monoclonal antibodies","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2064375261","doi":"https://doi.org/10.1158/1538-7445.am2011-558","mag":"2064375261"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-558","doi":"https://doi.org/10.1158/1538-7445.am2011-558","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-558","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089201601","display_name":"Palaniswami Rathanaswami","orcid":"https://orcid.org/0000-0001-9983-9444","observed_orcids":["https://orcid.org/0000-0001-9983-9444"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Palaniswami Rathanaswami","raw_affiliation_strings":["1Amgen British Columbia, Burnaby, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen British Columbia, Burnaby, British Columbia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021510563","display_name":"Oscar Chi-Chien Pan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oscar Pan","raw_affiliation_strings":["1Amgen British Columbia, Burnaby, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen British Columbia, Burnaby, British Columbia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077757906","display_name":"Sarah J. Ross","orcid":"https://orcid.org/0000-0001-8759-1728","observed_orcids":["https://orcid.org/0000-0001-8759-1728"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Ross","raw_affiliation_strings":["2AstraZeneca R&D, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca R&D, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108639408","display_name":"Chadwick King","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chadwick King","raw_affiliation_strings":["1Amgen British Columbia, Burnaby, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen British Columbia, Burnaby, British Columbia, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034901985","display_name":"Ian N. Foltz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian N. Foltz","raw_affiliation_strings":["1Amgen British Columbia, Burnaby, British Columbia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Amgen British Columbia, Burnaby, British Columbia, Canada","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111869571","display_name":"Paul Elvin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul Elvin","raw_affiliation_strings":["2AstraZeneca R&D, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2AstraZeneca R&D, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"558","last_page":"558"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heparanase","display_name":"heparanase","score":0.9829999804496765},{"id":"https://openalex.org/keywords/heparan-sulfate-proteoglycans","display_name":"heparan sulfate proteoglycans","score":0.9639999866485596},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8420000076293945},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/heparan-sulfate-mimetics","display_name":"heparan sulfate mimetics","score":0.7409999966621399}],"concepts":[{"id":"https://openalex.org/C2777478136","wikidata":"https://www.wikidata.org/wiki/Q909646","display_name":"Heparanase","level":4,"score":0.9900683164596558},{"id":"https://openalex.org/C2778041096","wikidata":"https://www.wikidata.org/wiki/Q424668","display_name":"Heparan sulfate","level":3,"score":0.7969286441802979},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6400786638259888},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5464592576026917},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5252715349197388},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.5006096363067627},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.49439311027526855},{"id":"https://openalex.org/C2780654058","wikidata":"https://www.wikidata.org/wiki/Q5376339","display_name":"Endoglycosidase","level":3,"score":0.4803268015384674},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.445814847946167},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4302448332309723},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.42079830169677734},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.41062402725219727},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3640689551830292},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3296610116958618},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29078084230422974},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20626848936080933},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19741693139076233},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08636713027954102}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-558","doi":"https://doi.org/10.1158/1538-7445.am2011-558","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-558","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413982521","https://openalex.org/W2126140637","https://openalex.org/W2020098579","https://openalex.org/W2531138060","https://openalex.org/W2784552595","https://openalex.org/W2064040661","https://openalex.org/W2323982843","https://openalex.org/W2963520047","https://openalex.org/W3179831102","https://openalex.org/W4288036113"],"abstract_inverted_index":{"Abstract":[0],"Modification":[1],"of":[2,33,43,71,85,114,165,184,196,201],"heparan":[3,58,134,185],"sulfate":[4,59,135,186],"proteoglycans":[5],"(HSPG)":[6],"in":[7,29,62,82,127,140],"the":[8,31,34,54,141,182,197,202],"tumour":[9,17,20],"microenvironment":[10],"can":[11],"have":[12,98],"a":[13,83,128,177],"significant":[14],"influence":[15],"on":[16],"cell":[18,38,152],"behavior,":[19],"growth":[21],"and":[22,37,46,79,91,123,157,163],"metastasis.":[23],"HSPG":[24,40,63],"play":[25],"an":[26,51,171],"important":[27],"role":[28],"shaping":[30],"integrity":[32],"extracellular":[35],"matrix,":[36],"surface":[39,153],"are":[41],"determinants":[42],"cell-cell":[44],"interactions":[45],"receptor":[47],"function.":[48],"Heparanase":[49],"(Hpa1),":[50],"endoglycosidase,":[52],"cleaves":[53],"glycosidic":[55],"bonds":[56],"within":[57],"domains":[60],"resulting":[61],"with":[64,76,93,108,138,161,170],"impaired":[65],"or":[66],"altered":[67],"functionality.":[68],"Elevated":[69],"expression":[70],"heparanase":[72,107,125,155,168],"has":[73],"been":[74],"correlated":[75],"disease":[77],"progression":[78],"poor":[80],"survival":[81],"number":[84,113],"human":[86,95,101,146],"cancers.":[87],"Using":[88],"Xenomouse\u2122":[89],"technology":[90],"immunising":[92],"recombinant":[94,120],"Hpa1,":[96],"we":[97],"generated":[99],"fully":[100],"monoclonal":[102],"antibodies":[103,115,149],"that":[104],"bind":[105],"to":[106,118,159,181],"high":[109],"affinity":[110],"(<100pM).":[111],"A":[112],"were":[116],"shown":[117],"inhibit":[119],"human,":[121],"murine":[122],"cynomolgus":[124],"activity":[126,156,169],"HTRF":[129],"(homogeneous":[130],"time":[131],"resolved":[132],"fluorescence)":[133],"degradation":[136],"assay":[137],"IC50s":[139],"nM":[142],"range":[143],"(0.2-3nM)":[144],"for":[145,205],"Hpa1.":[147],"The":[148],"also":[150],"inhibited":[151],"localised":[154],"appeared":[158],"interfere":[160],"secretion":[162],"activation":[164],"heparanase.":[166],"Targeting":[167],"inhibitory":[172],"therapeutic":[173],"antibody":[174],"may":[175],"be":[176],"promising":[178],"alternative":[179],"strategy":[180],"use":[183],"mimetics.":[187],"Citation":[188],"Format:":[189],"{Authors}.":[190],"{Abstract":[191],"title}":[192],"[abstract].":[193],"In:":[194],"Proceedings":[195],"102nd":[198],"Annual":[199],"Meeting":[200],"American":[203],"Association":[204],"Cancer":[206,216],"Research;":[207],"2011":[208],"Apr":[209],"2-6;":[210],"Orlando,":[211],"FL.":[212],"Philadelphia":[213],"(PA):":[214],"AACR;":[215],"Res":[217],"2011;71(8":[218],"Suppl):Abstract":[219],"nr":[220],"558.":[221],"doi:10.1158/1538-7445.AM2011-558":[222]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2016-06-24T00:00:00"}